Neoimmunetech to Brief Investors on R&D Developments
Neoimmunetech plans to hold a briefing for securities analysts and institutional investors in Seoul on Nov. 4–5, 2026, to discuss its research and development status.
Neoimmunetech plans to hold a briefing for securities analysts and institutional investors in Seoul on Nov. 4–5, 2026, to discuss its research and development status.